Boston Scientific: Launching EXALT-D During a Pandemic

article image

Boston Scientific’s EXALT-D duodenoscope was expected to be a blockbuster product, with an all-hands-on-deck launch planned for mid-2020. Then the pandemic hit

Boston Scientific a category leader in endoscopy, with a track record of producing high-quality products for a business unit that generates $3 billion in revenues. One of its more challenging goals in recent years has been development of a single-use duodenoscope, which aims to address provider and government concerns about the infection rates found in reusable duodenoscopes. In December 2019, the company became first to get FDA clearance for such a scope, the EXALT Model D Single Use Duodenoscope.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: